Prime Minister Narendra Modi on Wednesday gifted the nation with CAR-T Cell Therapy, India’s first indigenous cancer cell therapy, developed by Indian innovators, during the ongoing Emerging Science, Technology and Innovation Conclave (ESTIC) 2025. Among these therapies is NexCAR19, the world’s first humanised CAR-T therapy developed in India by ImmunoACT, a ground-breaking innovation supported by Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC).

The Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a breakthrough in cancer treatment, with global clinical trials showing promising results in end-stage patients, especially those suffering from Acute Lymphocytic Leukaemia. According to the Ministry of Science and Technology, NexCA

See Full Page